Trials / Conditions / Systemic Sclerosis Associated Interstitial Lung Disease
Systemic Sclerosis Associated Interstitial Lung Disease
5 registered clinical trials studyying Systemic Sclerosis Associated Interstitial Lung Disease — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-rel NCT07080125 | Boehringer Ingelheim | — |
| Recruiting | A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, E NCT06189495 | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 2 |
| Recruiting | A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung NCT05878717 | GlaxoSmithKline | Phase 2 / Phase 3 |
| Unknown | "Pulmonary Rehabilitation Program in Patients With Interstitial Lung Disease Associated With Systemic Sclerosi NCT06105073 | Coordinación de Investigación en Salud, Mexico | — |
| Terminated | Abituzumab in SSc-ILD NCT02745145 | EMD Serono Research & Development Institute, Inc. | Phase 2 |